ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Friday, 13 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Promoter Reclassification

Sun Pharma Advanced Research Company Promoter Reclassification

Sun Pharma Advanced Research received NSE and BSE no-objection letters dated 12 November 2026 to reclassify three promoter group members to Public under Regulation 31A. The filing is a regulatory reclassification with no monetary value.

Source

BSE filing, NSE: SPARC. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sun Pharma Advanced Research Company Ltd: key numbers

Share price
₹212.35
Market cap
₹6,891 Cr
Revenue (annual)
₹1,879 Cr
Net profit (annual)
₹1,553 Cr
P/E (TTM)
4.2×Sector 43.8×
Promoter holding
65.67%+0.00% QoQ
FII holding
3.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sun Pharma Advanced Research Company Ltd

All →

Other promoter reclassification announcements

All →